T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$1.76B |
| 2 |
Eli Lilly
LLY
|
+$1.4B |
| 3 |
Bank of America
BAC
|
+$1.3B |
| 4 |
Tesla
TSLA
|
+$1.19B |
| 5 |
Wells Fargo
WFC
|
+$784M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$6.47B |
| 2 |
Amazon
AMZN
|
+$3.71B |
| 3 |
Yum! Brands
YUM
|
+$2.84B |
| 4 |
Salesforce
CRM
|
+$2.77B |
| 5 |
Fortive
FTV
|
+$2.41B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.06% |
| 2 | Healthcare | 18.72% |
| 3 | Consumer Discretionary | 14.62% |
| 4 | Financials | 10.36% |
| 5 | Communication Services | 9.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
551
Bath & Body Works
BBWI
$3.69B
| $73.2M | 0.01% |
2,243,890
-4,120,363
| -65% | -$145M |
|
|
DISH
552
DELISTED
DISH Network Corp.
DISH
| $72.5M | 0.01% |
5,245,130
+415
| +0% | +$7.34K |
|
553
Replimune Group
REPL
$1.45B
| $72M | 0.01% |
4,171,171
-1,711,360
| -29% | -$32.6M |
|
554
Revolution Medicines
RVMD
$43.6B
| $72M | 0.01% |
3,652,628
+1,414,774
| +63% | +$31.1M |
|
555
Element Solutions
ESI
$9.54B
| $71.7M | 0.01% |
4,407,127
-17,437,377
| -80% | -$325M |
|
556
Boston Scientific
BSX
$74.7B
| $71.7M | 0.01% |
1,850,313
+7,738
| +0.4% | +$310K |
|
557
Acadia Realty Trust
AKR
$2.87B
| $71.3M | 0.01% |
5,646,525
+10,917
| +0.2% | +$175K |
|
558
Li Auto
LI
$12B
| $71.1M | 0.01% |
3,090,017
+1,113,657
| +56% | +$34.7M |
|
559
The Ensign Group
ENSG
$10.7B
| $71M | 0.01% |
892,883
-1,153,895
| -56% | -$95.5M |
|
560
EXL Service
EXLS
$5.22B
| $70.8M | 0.01% |
2,402,830
+1,325
| +0.1% | +$43.2K |
|
561
Madison Square Garden
MSGS
$10.1B
| $70.6M | 0.01% |
516,783
+70,509
| +16% | +$10.9M |
|
562
Fate Therapeutics
FATE
$314M
| $70.4M | 0.01% |
3,141,653
-1,841,850
| -37% | -$53.2M |
|
563
CDW
CDW
$17.3B
| $70.3M | 0.01% |
450,218
-466
| -0.1% | -$79.9K |
|
564
Workiva
WK
$3.71B
| $69.6M | 0.01% |
894,720
-2,127,337
| -70% | -$145M |
|
565
Palo Alto Networks
PANW
$320B
| $69.2M | 0.01% |
845,144
-355,924
| -30% | -$30.8M |
|
566
Douglas Emmett
DEI
$1.99B
| $69.1M | 0.01% |
3,856,434
-1,113,122
| -22% | -$23.7M |
|
567
AMN Healthcare
AMN
$1.31B
| $68.7M | 0.01% |
647,892
-78,272
| -11% | -$8.58M |
|
568
CACI
CACI
$14.8B
| $68.6M | 0.01% |
262,638
-17,847
| -6% | -$5.03M |
|
569
Sphere Entertainment
SPHR
$6.35B
| $68.2M | 0.01% |
1,547,239
+241,244
| +18% | +$13.5M |
|
570
Option Care Health
OPCH
$3.61B
| $68.2M | 0.01% |
2,166,907
-7,222,531
| -77% | -$231M |
|
571
Shoals Technologies Group
SHLS
$1.4B
| $67.5M | 0.01% |
3,130,687
-10,295,808
| -77% | -$230M |
|
572
PTC
PTC
$16B
| $67.5M | 0.01% |
644,877
-3,761,462
| -85% | -$429M |
|
573
10x Genomics
TXG
$7.63B
| $66.9M | 0.01% |
2,349,229
+1,010,643
| +76% | +$38.5M |
|
574
Edwards Lifesciences
EW
$53.4B
| $66.6M | 0.01% |
806,466
-448
| -0.1% | -$43.1K |
|
575
Graphic Packaging
GPK
$3.48B
| $66.3M | 0.01% |
3,357,217
+591,458
| +21% | +$13M |
|
Similar funds
T. Rowe Price Associates's Q3 2022 Portfolio in Review
As of Q3 2022, T. Rowe Price Associates held 3,114 positions worth $610B, down 23% from $791B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
T. Rowe Price Associates withdrew a net $168B in Q3 2022, closing 171 positions and reducing 1,248 holdings. Its most notable exit was Alcon, an estimated $1.51B position sold in full.
By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, T. Rowe Price Associates opened a new position in Corebridge Financial worth $194M.
- T. Rowe Price Associates's largest Q3 2022 buy was Corebridge Financial: 9,831,688 shares worth $194M.
- T. Rowe Price Associates added most to ExxonMobil in Q3 2022, an estimated $1.76B increase.
- T. Rowe Price Associates's biggest Q3 2022 reduction was Microsoft, cutting an estimated $6.47B.
- T. Rowe Price Associates fully exited Alcon in Q3 2022, selling an estimated $1.51B.
- T. Rowe Price Associates's ten largest holdings make up 31% of its $610B portfolio in Q3 2022.
- T. Rowe Price Associates opened 154 new positions and closed 171 in Q3 2022.
- T. Rowe Price Associates's portfolio value fell 23% quarter-over-quarter to $610B.
Based on T. Rowe Price Associates's 13F filing for Q3 2022, filed 14 Nov 2022.